Literature DB >> 15377551

Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders.

T Nakamura1, T Inatomi, C Sotozono, T Amemiya, N Kanamura, S Kinoshita.   

Abstract

BACKGROUND/AIMS: To determine outcomes of transplants of cultivated autologous oral epithelial cells in patients with severe ocular surface disorders.
METHODS: The eyes (n = 6) of four patients with Stevens-Johnson syndrome (three eyes) or chemical burns (three eyes) were studied. Autologous oral epithelial cells, grown for 2-3 weeks on a denuded amniotic membrane carrier in the presence of 3T3 fibroblasts, were air lifted. The resultant sheet was transplanted onto the damaged eye, and acceptance of the sheet by the corneal surface was confirmed 48 hours after surgery. The success of ocular surface reconstruction, graft survival, changes in visual acuity, and postoperative complications were assessed and the quality of the cultivated oral epithelial sheet was evaluated histologically.
RESULTS: At 48 hours after transplant, the entire corneal surface of all six eyes was free of epithelial defects indicating complete survival of the transplanted oral epithelium. Visual acuity was improved in all eyes. During follow up (mean 13.8 (SD 2.9) months), the corneal surface remained stable, although all eyes manifested mild peripheral neovascularisation.
CONCLUSIONS: Autologous oral epithelial cells grown on denuded amniotic membrane can be transplanted to treat severe ocular surface disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15377551      PMCID: PMC1772364          DOI: 10.1136/bjo.2003.038497

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  33 in total

1.  Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease.

Authors:  T Nakamura; K Nishida; A Dota; M Matsuki; K Yamanishi; S Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

2.  Mucous membrane grafts in chemical (lye) burns.

Authors:  P H BALLEN
Journal:  Am J Ophthalmol       Date:  1963-02       Impact factor: 5.258

3.  Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency.

Authors:  S C Tseng; P Prabhasawat; K Barton; T Gray; D Meller
Journal:  Arch Ophthalmol       Date:  1998-04

4.  Changes in conjunctival clusterin expression in severe ocular surface disease.

Authors:  Takahiro Nakamura; Kohji Nishida; Atsuyoshi Dota; Shigeru Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

5.  Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation.

Authors:  K Tsubota; Y Satake; M Kaido; N Shinozaki; S Shimmura; H Bissen-Miyajima; J Shimazaki
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

6.  Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas.

Authors:  J C Kim; S C Tseng
Journal:  Cornea       Date:  1995-09       Impact factor: 2.651

7.  Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns.

Authors:  J Shimazaki; H Y Yang; K Tsubota
Journal:  Ophthalmology       Date:  1997-12       Impact factor: 12.079

8.  Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease.

Authors:  I R Schwab; M Reyes; R R Isseroff
Journal:  Cornea       Date:  2000-07       Impact factor: 2.651

9.  Cultivated corneal epithelial stem cell transplantation in ocular surface disorders.

Authors:  N Koizumi; T Inatomi; T Suzuki; C Sotozono; S Kinoshita
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

10.  Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium.

Authors:  G Pellegrini; C E Traverso; A T Franzi; M Zingirian; R Cancedda; M De Luca
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

View more
  90 in total

1.  [Preparation of the amniotic membrane with the waterjet].

Authors:  P Schreier; J Darmann; C Jürgens; R Schlüter; J Giebel; F Tost
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

2.  Bilateral limbal stem cell deficiency with chromosomal translocation of 3p and 9p.

Authors:  Tomohiko Usui; Suguru Nakagawa; Seiichi Yokoo; Tatsuya Mimura; Satoru Yamagami; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

3.  Epithelial proliferative potential of organ cultured corneoscleral rims; implications for allo-limbal transplantation and eye banking.

Authors:  V A Shanmuganathan; A P Rotchford; A B Tullo; A Joseph; I Zambrano; H S Dua
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

4.  Combination treatment of intravenous immunoglobulin and cultivated oral mucosal epithelial transplantation for ocular cicatricial pemphigoid.

Authors:  Y Uchino; S Takahashi; M Uchino; J Shimazaki
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

5.  Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group.

Authors:  Valerie P J Saw; Darwin Minassian; John K G Dart; Andrew Ramsay; Hugo Henderson; Stefan Poniatowski; Ruth M Warwick; Suzanne Cabral
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

Review 6.  Epithelial stem cells of the eye surface.

Authors:  R P Revoltella; S Papini; A Rosellini; M Michelini
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

7.  Limbal stem cell disease: Treatment and advances in technology.

Authors:  Hall F Chew
Journal:  Saudi J Ophthalmol       Date:  2011-05-24

8.  Development of a cell sheet transportation technique for regenerative medicine.

Authors:  Yoshinori Oie; Takayuki Nozaki; Hiroshi Takayanagi; Susumu Hara; Ryuhei Hayashi; Shizu Takeda; Keisuke Mori; Noboru Moriya; Takeshi Soma; Motokazu Tsujikawa; Kazuo Saito; Kohji Nishida
Journal:  Tissue Eng Part C Methods       Date:  2013-11-26       Impact factor: 3.056

9.  A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.

Authors:  Aisha N Hasan; Wouter J Kollen; Deepa Trivedi; Annamalai Selvakumar; Bo Dupont; Michel Sadelain; Richard J O'Reilly
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

10.  Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Seema Kamala Muralidharan; Sumathi Arumugam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.